logo

2.87

2.87 (-3.84%)

As of Mar 06, 2024

Oramed Pharmaceuticals Inc. [ORMP]

Source: 

Company Overview

We are a pharmaceutical company currently engaged in the research and development of innovative pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. We utilize Clinical Research Organizations, or CROs, to conduct our clinical studies.

CountryUnited States
Headquartersnew yorknew york
Phone Number646-844-1164
Industry
manufacturing
CEONadav Kidron
Websitewww.oramed.com